Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



ENRIGHT PATRICK G Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1585, valued at $171.5k
05/12/2023 4 ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $7.7, valued at $154k
02/08/2023 4 ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 1,714,285 shares @ $7, valued at $12M
11/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/31/2022 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns: Granted 40,000 options to buy @ $0.5, valued at $20k
05/26/2022 4 ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 9,925 options to buy @ $16.14, valued at $160.2k
04/29/2022 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed of 175,000 shares @ $0
Disposed of 1,964,771 shares @ $0
Acquired 5,023 shares @ $0
Acquired 2,152 shares @ $0
Acquired 7,175 shares @ $0
Acquired 588 shares @ $0
Acquired 252 shares @ $0
Acquired 840 shares @ $0
04/21/2022 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 1,355,000 shares @ $3.69, valued at $5M
04/05/2022 4 ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Bought 333,333 shares @ $15, valued at $5M
02/02/2022 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Bought 175,000 shares @ $27, valued at $4.7M
01/27/2022 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Exercised (in-or-at-the-money) 1,477,125 options to buy @ $13.2, valued at $19.5M
08/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2021 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 2,246 shares @ $0
07/20/2021 4 Longitude Capital Partners II, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.
Txns: Converted 3,344,038 shares @ $0
Bought 150,000 shares @ $20, valued at $3M
Converted 8,774,007 options to buy @ $0
Converted 5,654,529 options to buy @ $0
Converted 2,291,665 options to buy @ $0
Converted 2,500,000 options to buy @ $0.01, valued at $25k
Converted 500,000 warrants @ $0.05, valued at $25k
Converted 645,160 options to buy @ $0.01, valued at $6.5k
Converted 129,032 warrants @ $0.05, valued at $6.5k
06/01/2021 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns: Granted 40,000 options to buy @ $2.59, valued at $103.6k
05/18/2021 4 ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Converted 2,187,504 shares @ $0
Bought 909,090 shares @ $11, valued at $10M
Converted 2,187,504 preferred shares @ $0
05/17/2021 4 ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 9,925 options to buy @ $11, valued at $109.2k
05/11/2021 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Talaris Therapeutics, Inc.
Txns: Converted 2,985,775 shares @ $0
Bought 235,000 shares @ $17, valued at $4M
Converted 1,308,410 preferred shares @ $0
Converted 1,271,027 preferred shares @ $0
Converted 406,338 preferred shares @ $0
04/15/2021 4 Longitude Venture Partners IV, L.P. (10% Owner) has filed a Form 4 on Eargo, Inc.
Txns: Disposed of 1,000,000 shares @ $0
Acquired 5,012 shares @ $0
01/05/2021 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns: Granted 8,149 options to buy @ $3.46, valued at $28.2k
11/18/2020 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on 89bio, Inc.
Txns: Disposed of 850,000 shares @ $0
Acquired 2,973 shares @ $0
Acquired 2,080 shares @ $0
Acquired 891 shares @ $0
11/13/2020 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Sold 3,223 shares @ $145.8102, valued at $469.9k
Sold 5,083 shares @ $147.0032, valued at $747.2k
Sold 1,623 shares @ $147.6122, valued at $239.6k
11/04/2020 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Exercised 9,929 options to buy @ $0
10/22/2020 4 Longitude Venture Partners IV, L.P. (10% Owner) has filed a Form 4 on Eargo, Inc.
Txns: Converted 3,685,358 shares @ $0
Bought 233,333 shares @ $18, valued at $4.2M
Converted 3,685,358 preferred shares @ $0
10/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2020 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns: Granted 8,379 options to buy @ $3.38, valued at $28.3k
09/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/01/2020 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Molecular Templates, Inc.
Txns: Sold 2,447 shares @ $10.7461, valued at $26.3k
Sold 1,049 shares @ $10.7461, valued at $11.3k
08/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2020 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Converted 2,007,225 shares @ $0
Converted 187,154 shares @ $0
Bought 625,000 shares @ $16, valued at $10M
Converted 15,000,000 convertible preferred @ $0
Converted 1,398,600 convertible preferred @ $0
07/14/2020 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on 89bio, Inc.
Txns: Bought 109,090 shares @ $27.5, valued at $3M
07/02/2020 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aptinyx Inc.
Txns: Granted 5,436 options to buy @ $4.17, valued at $22.7k
05/29/2020 4 ENRIGHT PATRICK G (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Sold 7,840 shares @ $0
Granted 15,398 options to buy @ $17.11, valued at $263.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy